TransBiotec, Inc. (IMLE) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 9 transactions totaling $1.1M, demonstrating a bullish sentiment with $1.1M in net insider flow. The most recent transaction on Feb 15, 2020 involved a purchase of 0 shares valued at $0.
No significant insider buying has been recorded for IMLE in the recent period.
No significant insider selling has been recorded for IMLE in the recent period.
Based on recent SEC filings, insider sentiment for IMLE is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at TransBiotec, Inc. (IMLE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading IMLE stock, having executed 9 transactions in the past 90 days. The most active insider is Charles Warren Bennington (Executive), who has made 1 transactions totaling $560.0K.
Get notified when executives and directors at IMLE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 15, 2020 | John Graham Gary | Executive | Purchase | 0 | $N/A | $0 | |
| Dec 31, 2019 | D. Moore Kevin | Executive | Award | 800,000 | $N/A | $0 | |
| Dec 12, 2019 | John Graham Gary | Executive | Purchase | 0 | $N/A | $0 | |
| Nov 30, 2019 | D. Moore Kevin | Executive | Award | 800,000 | $N/A | $0 | |
| Oct 31, 2019 | D. Moore Kevin | Executive | Award | 800,000 | $N/A | $0 | |
| Aug 28, 2019 | Warren Bennington Charles | Executive | Purchase | 14,000,000 | $0.04 | $560.0K | Large |
| Aug 28, 2019 | A. Lanphere Michael | Executive | Purchase | 5,206,430 | $0.10 | $520.6K | Large |
| Aug 28, 2019 | A. Lanphere Michael | Executive | Purchase | 21,400,745 | $N/A | $0 | |
| Aug 28, 2019 | M. Mishal Devadatt | Executive | Purchase | 13,134,420 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 6 | $1.1M | 100.0% |
Award(A) | 3 | $0 | 0.0% |
Insiders at TransBiotec, Inc. are accumulating shares at an accelerated pace. With 5 insiders making 9 transactions totaling $1.1M in purchases versus $0 in sales, the net buying activity of $1.1M signals strong executive confidence. Charles Warren Bennington (Executive) leads the buying activity with $560.0K in transactions across all time.